| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 10 insiders with recent SEC Form 4 filings, including 12 buys and 11 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 11.33M | $171.53M | - | |
| CEO | 1.85M | $27.93M | - | |
| COO | 734.6K | $11.12M | - | |
| CFO | 589.1K | $8.92M | - | |
| VP | 557.4K | $8.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | Tang Kevin86 | Director | Buy | 1,300,000 | $10.45 | $13,590,000.00 | +4.0% | +12.6% | - | |
| Aug 1, 2025 | Keenan Greg | Chief Medical Officer | Sell | 20,000 | $10.50 | $210,000.00 | -13.0% | +15.5% | - | |
| Mar 7, 2025 | Keenan Greg | Chief Medical Officer | Sell | 8,305 | $8.23 | $68,350.15 | -5.1% | -0.7% | +75.7% | |
| Mar 4, 2025 | Greenleaf Peter49 | Chief Executive Officer | Sell | 360,540 | $7.96 | $2,871,124.24 | -8.8% | -1.5% | +86.1% | |
| Mar 4, 2025 | Miller Joseph M50 | Chief Financial Officer | Sell | 118,013 | $7.96 | $939,611.68 | -8.9% | -1.5% | +86.1% | |
| Mar 4, 2025 | Robertson Stephen P. | EVP, General Counsel | Sell | 122,479 | $7.96 | $975,223.44 | -10.2% | -1.5% | +86.1% | |
| Mar 4, 2025 | Donley Matthew Maxwell54 | Chief Operating Officer | Sell | 124,893 | $7.96 | $994,424.72 | -8.1% | -1.5% | +86.1% | |
| Mar 4, 2025 | Tang Kevin86 | Director | Buy | 1,600,000 | $7.95 | $12,713,125.64 | +2.9% | -1.5% | +86.1% | |
| Mar 3, 2025 | Keenan Greg | Chief Medical Officer | Sell | 12,239 | $8.00 | $97,912.00 | -7.0% | -0.3% | +77.4% | |
| Dec 9, 2024 | Tang Kevin86 | Director | Buy | 1,200,000 | $9.02 | $10,822,000.00 | +5.3% | -10.5% | +70.1% |